Bitget App
Aqlliroq savdo qiling
Kripto sotib olishBozorlarSavdoFyuchersStocksEarnTashkilotAI & More
Kashiv Biosciences Amneal Pharmaceuticals tomonidan sotib olinishi bilan rozi bo‘ldi, bu harakat to‘liq integratsiyalashgan global biosimilarlar sohasida yetakchi kompaniya yaratishga qaratilgan.

Kashiv Biosciences Amneal Pharmaceuticals tomonidan sotib olinishi bilan rozi bo‘ldi, bu harakat to‘liq integratsiyalashgan global biosimilarlar sohasida yetakchi kompaniya yaratishga qaratilgan.

老虎证券老虎证券2026/04/22 10:23
Asl nusxasini ko'rsatish
Ushbu bitim ikki tomonning ilmiy-tadqiqot, ishlab chiqarish va tijoratlashtirish sohalaridagi ustun resurslarini birlashtirib, kuchli sinergiya samaralarini yuzaga keltiradi. Ushbu strategik birlashuv orqali yangi tashkilot biosimilyar dori vositalarining butun qiymat zanjirini – dastlabki tadqiqotdan tortib, global bozorga chiqishgacha – qamray oladigan salohiyatga ega bo‘ladi va shu bilan tez sur’atlarda o‘sib borayotgan biotibbiyot bozoridagi raqobatbardoshligini yanada kuchaytiradi. Bozor tahlilchilari ushbu birlashuv sanoat ko‘rinishini o‘zgartirib, bemorlar uchun ko‘proq mos va yuqori sifatli davolash usullari imkonini yaratishini ta’kidlamoqda. Bitimning moliyaviy tafsilotlari va aniq jadvali hali ochiqlanmagan, odatdagi shartlar bajarilgandan so‘ng yakunlanishi kutilmoqda. Har ikki tomon boshqaruvchilari birlashuvdan keyingi rivojlanish istiqbollariga ishonch bildirar ekan, bu innovatsion terapiyalarning ommaviylashuvini tezlashtirib, uzoq muddatli barqaror qiymat yaratishini qayd etgan.
0
0

Mas'uliyatni rad etish: Ushbu maqolaning mazmuni faqat muallifning fikrini aks ettiradi va platformani hech qanday sifatda ifodalamaydi. Ushbu maqola investitsiya qarorlarini qabul qilish uchun ma'lumotnoma sifatida xizmat qilish uchun mo'ljallanmagan.

PoolX: Aktivlarni kiriting va yangi tokenlar oling.
APR 12% gacha. Yangi tokenlar airdropi.
Qulflash!

Sizga ham yoqishi mumkin

BUZZ-Fast LNG qurilmasi to'xtatildi, New Fortress Energy aksiyalari pasaydi

5-oktabr – AQShning suyuq gaz kompaniyasi New Fortress Energy (NFE.O) aksiyalari 14.3%ga tushib, tarixiy minimum – $5.63ga yetdi. NFE xabariga ko‘ra, Fast LNG qurilmasi ichidagi gaz turbinasining mexanik nosozligi tufayli to‘xtatilgan. Kompaniya ta’kidlashicha, turbin ishlab chiqaruvchisi bilan faol hamkorlik qilayotgan bo‘lib, qurilmaning ishga qaytishini tezlashtirishga harakat qilmoqda. NFE kutmoqdaki, Fast LNG qurilmasi to‘rtinchi chorakda ishga qaytadi. Ushbu savdo kunidagi pasayish hisobga olinganda, kompaniya aksiyalari yil boshidan buyon 90.1%ga arzonlashgan. (Reuters avtomatik tarzda ma’lumotni bir necha tilga tarjima qiladi. Avtomatik tarjimalar noto‘g‘ri yoki kontekst yetarli bo‘lmasligi mumkin. Reuters avtomatik tarjima matnining aniqligi uchun javobgar emas va uni faqat o‘quvchilar qulayligi uchun taqdim etadi. Avtomatik tarjima xizmatidan kelib chiqadigan zarar yoki yo‘qotishlar uchun Reuters javobgar emas.)

路透社•2026/10/05 16:41

New Fortress Energy Fast LNG qurilmasi to‘xtatilganini bildiradi, aktsiya narxi 14% ga quladi

Reuters, 5 October - New Fortress Energy (NFE.O) has announced on Monday that its Fast LNG plant has ceased operations due to a mechanical fault in its gas turbine, causing its share price to plunge 14% and reach a record low. The shutdown comes as LNG prices are rising and disrupts the production plans of the Fast LNG facility. Since the beginning of the year, the plant has exported one LNG shipment per month to Puerto Rico to help the US territory address its power supply challenges. Further details: According to regulatory filings by New Fortress Group, the company is actively cooperating with the turbine manufacturer to restore the floating LNG (FLNG) unit, which is a key component of its LNG business. The company expects the unit to resume operations in the fourth quarter. According to prior disclosures, the annual production capacity of the Fast LNG facility is 1.4 million tons. (Note: Reuters provides its reporting in several automated translations for the convenience of non-English speakers. Automated translations may contain errors or lack necessary context, and Reuters does not guarantee the accuracy of automated translation texts and only provides them for convenience. Reuters is not liable for any damage or loss caused by the use of automated translations.)

路透社•2026/10/05 16:36